Limin Chemical Co Ltd

Limin Group released its 2026 interim report, with net profit attributable to the parent company of 274 million yuan, up 1.90% from the same period last year. Total operating revenue was 2.463 billion yuan, up 0.47% year-on-year, marking a second consecutive year of growth. Net cash inflow from operating activities was 146 million yuan, up 59.78% year-on-year. The company's latest asset-liability ratio was 40.47%, gross margin was 27.00%, ROE was 6.81%, and diluted earnings per share was 0.58 yuan.

Limin Chemical, a wholly owned subsidiary of Limin Shares, has renewed the Strategic Cooperation Framework Agreement with Syngenta Shanghai and Suken Biochemical. The new agreement runs until December 31, 2031. The company has granted Syngenta Shanghai exclusive distribution rights for the Jindasheng product for five years, and granted Suken Biochemical exclusive distribution rights for the Lvdasheng and Yousheng products for five years.